FALCO HOLDINGS Co., Ltd. (4671.T)
JPY 2332.0
(0.39%)
JPY 2332.0
(0.39%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.39 Billion JPY | -15.51% |
| 2022 | 12.3 Billion JPY | -26.67% |
| 2021 | 16.78 Billion JPY | 1.18% |
| 2020 | 16.58 Billion JPY | 26.94% |
| 2019 | 13.06 Billion JPY | -0.35% |
| 2018 | 13.11 Billion JPY | -3.42% |
| 2017 | 13.57 Billion JPY | 3.04% |
| 2016 | 13.17 Billion JPY | -6.82% |
| 2015 | 14.14 Billion JPY | 2.26% |
| 2014 | 13.82 Billion JPY | -19.17% |
| 2013 | 17.1 Billion JPY | -25.49% |
| 2012 | 22.95 Billion JPY | -0.31% |
| 2011 | 23.02 Billion JPY | -3.82% |
| 2010 | 23.94 Billion JPY | 8.31% |
| 2009 | 22.1 Billion JPY | 23.75% |
| 2008 | 17.86 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 11.36 Billion JPY | 9.34% |
| 2023 FY | 10.39 Billion JPY | -15.51% |
| 2023 Q2 | 10.71 Billion JPY | -3.97% |
| 2023 Q4 | 10.39 Billion JPY | -6.36% |
| 2023 Q3 | 11.1 Billion JPY | 3.6% |
| 2023 Q1 | 11.15 Billion JPY | -9.31% |
| 2022 Q4 | 12.3 Billion JPY | -9.72% |
| 2022 Q3 | 13.62 Billion JPY | -5.31% |
| 2022 Q1 | 14.62 Billion JPY | -12.86% |
| 2022 FY | 12.3 Billion JPY | -26.67% |
| 2022 Q2 | 14.39 Billion JPY | -1.57% |
| 2021 Q4 | 16.78 Billion JPY | 2.81% |
| 2021 Q2 | 16.69 Billion JPY | 0.16% |
| 2021 FY | 16.78 Billion JPY | 1.18% |
| 2021 Q1 | 16.66 Billion JPY | 0.5% |
| 2021 Q3 | 16.32 Billion JPY | -2.23% |
| 2020 FY | 16.58 Billion JPY | 26.94% |
| 2020 Q1 | 17.03 Billion JPY | 30.36% |
| 2020 Q2 | 15.9 Billion JPY | -6.63% |
| 2020 Q3 | 17.29 Billion JPY | 8.73% |
| 2020 Q4 | 16.58 Billion JPY | -4.08% |
| 2019 FY | 13.06 Billion JPY | -0.35% |
| 2019 Q4 | 13.06 Billion JPY | -9.45% |
| 2019 Q1 | 14.13 Billion JPY | 7.78% |
| 2019 Q2 | 13.18 Billion JPY | -6.68% |
| 2019 Q3 | 14.42 Billion JPY | 9.41% |
| 2018 Q3 | 13.27 Billion JPY | 2.95% |
| 2018 Q4 | 13.11 Billion JPY | -1.24% |
| 2018 FY | 13.11 Billion JPY | -3.42% |
| 2018 Q2 | 12.89 Billion JPY | -9.5% |
| 2018 Q1 | 14.24 Billion JPY | 4.95% |
| 2017 FY | 13.57 Billion JPY | 3.04% |
| 2017 Q4 | 13.57 Billion JPY | -5.96% |
| 2017 Q3 | 14.43 Billion JPY | 7.39% |
| 2017 Q2 | 13.44 Billion JPY | -3.1% |
| 2017 Q1 | 13.87 Billion JPY | 5.29% |
| 2016 Q2 | 13.19 Billion JPY | -3.73% |
| 2016 FY | 13.17 Billion JPY | -6.82% |
| 2016 Q3 | 13.68 Billion JPY | 3.73% |
| 2016 Q1 | 13.7 Billion JPY | -3.08% |
| 2016 Q4 | 13.17 Billion JPY | -3.73% |
| 2015 Q3 | 14.1 Billion JPY | 2.7% |
| 2015 FY | 14.14 Billion JPY | 2.26% |
| 2015 Q4 | 14.14 Billion JPY | 0.26% |
| 2015 Q2 | 13.73 Billion JPY | -1.2% |
| 2015 Q1 | 13.89 Billion JPY | 0.52% |
| 2014 Q4 | 13.82 Billion JPY | -7.55% |
| 2014 Q3 | 14.95 Billion JPY | 2.87% |
| 2014 Q2 | 14.53 Billion JPY | -3.29% |
| 2014 Q1 | 15.03 Billion JPY | -12.12% |
| 2014 FY | 13.82 Billion JPY | -19.17% |
| 2013 Q2 | 20.88 Billion JPY | -7.65% |
| 2013 Q1 | 22.6 Billion JPY | -1.52% |
| 2013 FY | 17.1 Billion JPY | -25.49% |
| 2013 Q3 | 19.29 Billion JPY | -7.61% |
| 2013 Q4 | 17.1 Billion JPY | -11.33% |
| 2012 Q3 | 22.7 Billion JPY | 0.29% |
| 2012 Q1 | 23.32 Billion JPY | 1.29% |
| 2012 Q4 | 22.95 Billion JPY | 1.1% |
| 2012 Q2 | 22.64 Billion JPY | -2.94% |
| 2012 FY | 22.95 Billion JPY | -0.31% |
| 2011 FY | 23.02 Billion JPY | -3.82% |
| 2011 Q1 | 24.72 Billion JPY | 3.25% |
| 2011 Q2 | 24.74 Billion JPY | 0.08% |
| 2011 Q3 | 24.48 Billion JPY | -1.03% |
| 2011 Q4 | 23.02 Billion JPY | -5.95% |
| 2010 FY | 23.94 Billion JPY | 8.31% |
| 2010 Q4 | 23.94 Billion JPY | -10.42% |
| 2010 Q3 | 26.73 Billion JPY | -1.3% |
| 2010 Q1 | 26.81 Billion JPY | 0.0% |
| 2010 Q2 | 27.08 Billion JPY | 0.98% |
| 2009 FY | 22.1 Billion JPY | 23.75% |
| 2009 Q3 | 21.13 Billion JPY | 0.0% |
| 2008 Q4 | 21.43 Billion JPY | 0.0% |
| 2008 FY | 17.86 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 42.14 Billion JPY | 75.331% |
| DNA Chip Research Inc. | 250.12 Million JPY | -4056.372% |
| Cosmo Bio Company,Limited | 1.84 Billion JPY | -462.859% |
| H.U. Group Holdings, Inc. | 152.84 Billion JPY | 93.199% |
| BML, Inc. | 40.85 Billion JPY | 74.551% |
| Human Metabolome Technologies, Inc. | 656.68 Million JPY | -1483.101% |
| Precision System Science Co., Ltd. | 2.25 Billion JPY | -361.289% |